[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2011 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- -2.73%
YoY- 71.66%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 1,773,256 1,806,964 1,786,980 1,520,981 1,537,593 1,563,526 1,541,312 9.76%
PBT 132,088 141,146 171,820 73,186 75,757 82,344 87,168 31.82%
Tax -37,856 -50,870 -55,576 -20,401 -21,620 -23,056 -24,772 32.57%
NP 94,232 90,276 116,244 52,785 54,137 59,288 62,396 31.53%
-
NP to SH 92,860 88,796 114,740 52,157 53,620 58,808 61,936 30.89%
-
Tax Rate 28.66% 36.04% 32.35% 27.88% 28.54% 28.00% 28.42% -
Total Cost 1,679,024 1,716,688 1,670,736 1,468,196 1,483,456 1,504,238 1,478,916 8.80%
-
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.76%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 39,227 35,301 35,297 35,304 - - - -
Div Payout % 42.24% 39.76% 30.76% 67.69% - - - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.76%
NOSH 117,683 117,672 117,657 117,682 106,983 106,962 107,007 6.52%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 5.31% 5.00% 6.51% 3.47% 3.52% 3.79% 4.05% -
ROE 18.70% 18.45% 24.20% 10.14% 11.55% 13.03% 14.15% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 1,506.80 1,535.58 1,518.79 1,292.44 1,437.23 1,461.75 1,440.38 3.04%
EPS 78.91 75.46 97.52 44.32 50.12 54.98 57.88 22.88%
DPS 33.33 30.00 30.00 30.00 0.00 0.00 0.00 -
NAPS 4.22 4.09 4.03 4.37 4.34 4.22 4.09 2.10%
Adjusted Per Share Value based on latest NOSH - 117,655
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 123.04 125.37 123.99 105.53 106.68 108.48 106.94 9.77%
EPS 6.44 6.16 7.96 3.62 3.72 4.08 4.30 30.80%
DPS 2.72 2.45 2.45 2.45 0.00 0.00 0.00 -
NAPS 0.3446 0.3339 0.329 0.3568 0.3222 0.3132 0.3037 8.76%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 7.55 10.18 5.90 5.36 5.90 5.90 5.73 -
P/RPS 0.50 0.66 0.39 0.41 0.41 0.40 0.40 15.99%
P/EPS 9.57 13.49 6.05 12.09 11.77 10.73 9.90 -2.22%
EY 10.45 7.41 16.53 8.27 8.49 9.32 10.10 2.29%
DY 4.42 2.95 5.08 5.60 0.00 0.00 0.00 -
P/NAPS 1.79 2.49 1.46 1.23 1.36 1.40 1.40 17.74%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 -
Price 8.25 8.83 5.90 5.90 5.90 5.90 5.05 -
P/RPS 0.55 0.58 0.39 0.46 0.41 0.40 0.35 35.05%
P/EPS 10.46 11.70 6.05 13.31 11.77 10.73 8.72 12.85%
EY 9.56 8.55 16.53 7.51 8.49 9.32 11.46 -11.35%
DY 4.04 3.40 5.08 5.08 0.00 0.00 0.00 -
P/NAPS 1.95 2.16 1.46 1.35 1.36 1.40 1.23 35.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment